Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 4, keine Gesamtzahl für „Reagila“
Suchtreffer
Begriffe & Kennungen
Reagila · 4.8 · In the placebo-controlled part of the long-term maintenance of effect study EPS was 13.7% in the cariprazine g
Eintrag öffnenReagila · 4.8 · Lens opacity/Cataract Development of cataracts was observed in cariprazine non-clinical studies (see section 5
Eintrag öffnenReagila · 4.8 · Lens opacity/Cataract Development of cataracts was observed in cariprazine non-clinical studies (see section 5
Eintrag öffnenReagila · 4.8 · QT- prolongation With cariprazine no QT interval prolongation was detected compared to placebo in a clinical s
Eintrag öffnenReagila · 4.8 · QT- prolongation With cariprazine no QT interval prolongation was detected compared to placebo in a clinical s
Eintrag öffnenReagila · 4.8 · Reporting of suspected adverse reactions
Eintrag öffnenReagila · 4.8 · Reporting of suspected adverse reactions
Eintrag öffnenReagila · 4.8 · Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows con
Eintrag öffnenReagila · 4.8 · Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows con
Eintrag öffnenReagila · 4.8 · Skin and Pruritus subcutaneou Rash s tissue disorders Musculoskel Blood creatine Rhabdomyolys etal and phospho
Eintrag öffnenReagila · 4.8 · Summary of the safety profile
Eintrag öffnenReagila · 4.8 · Summary of the safety profile
Eintrag öffnenReagila · 4.8 · Table 1 Adverse drug reactions occurring in patients with schizophrenia MedDRA Very common Common Uncommon Rar
Eintrag öffnenReagila · 4.8 · Table 1 Adverse drug reactions occurring in patients with schizophrenia MedDRA Very common Common Uncommon Rar
Eintrag öffnenReagila · 4.8 · Tabulated list of adverse reactions
Eintrag öffnenReagila · 4.8 · Tabulated list of adverse reactions
Eintrag öffnenReagila · 4.8 · The most frequently reported adverse drug reactions (ADRs) with cariprazine in the dose range (1.5-6 mg) were
Eintrag öffnenReagila · 4.8 · The most frequently reported adverse drug reactions (ADRs) with cariprazine in the dose range (1.5-6 mg) were
Eintrag öffnenReagila · 4.8 · Venous thromboembolism (VTE) Cases of VTE, including cases of pulmonary embolism and cases of deep vein thromb
Eintrag öffnenReagila · 4.8 · Weight changes In the short-term studies, there were slightly greater mean increases in body weight in the car
Eintrag öffnen